Clinical Trials Logo

Impotence clinical trials

View clinical trials related to Impotence.

Filter by:

NCT ID: NCT03830164 Completed - Clinical trials for Prostate Adenocarcinoma

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

Start date: November 20, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well pentoxifylline, atorvastatin, and vitamin E (PAVE) work in treating patients with erectile dysfunction after radiation therapy for prostate cancer. Atorvastatin may reduce high cholesterol. Pentoxifylline and vitamin E may enhance blood flow. Giving PAVE may work better in treating prostate cancer patients with post-radiation therapy erectile dysfunction.

NCT ID: NCT01383018 Completed - Clinical trials for Erectile Dysfunction

PROPPER Prospective Registry of Outcomes With Penile Prosthesis

PROPPER
Start date: June 13, 2011
Phase:
Study type: Observational

The purpose of this observational registry is to collect and better understand "real-world" outcomes for men undergoing penile implant surgery to treat erectile dysfunction.

NCT ID: NCT00906269 Active, not recruiting - Prostatic Neoplasms Clinical Trials

Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer

HBOT
Start date: July 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if adding hyperbaric oxygen therapy, a therapy that delivers oxygen under slight pressure, to a drug treatment of PDE5I (such as Viagra, Levitra, Cialis)for men following surgery for prostate cancer will result in more men being able to continue to have erections.

NCT ID: NCT00882934 Completed - Clinical trials for Erectile Dysfunction

The Management of Erectile Dysfunction With Placebo Only

DAFA06
Start date: October 2006
Phase: N/A
Study type: Interventional

Placebo-controlled randomized clinical trials (RCT) are the gold standard to provide applicable evidence for clinical practice. A vast number of RCTs for treatment of several disorders has shown a mean placebo effect of 30%. Erectile dysfunction (ED) is a high prevalent disease and its first-line therapy is oral phosphodiesterase type-5 inhibitor (iPDE5) (i.e., sildenafil, vardenafil and tadalafil). Although the placebo effect in iPDE5 RCT occurred at a rate as high as 50%, in the last decade, with the revolutionary discovery of effective pharmacotherapy for ED, oral iPDE5 has become one of the most common prescribed drugs for men. The objective of this study is to evaluate the influence of patients' awareness on the composition of the therapeutic drug in the outcomes of the oral treatment for ED.

NCT ID: NCT00654082 Completed - Spinal Cord Injury Clinical Trials

A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction

Start date: September 2002
Phase: Phase 4
Study type: Interventional

To demonstrate the efficacy, safety and tolerability of sildenafil administered orally, as required, approximately 1 hour prior to sexual activity to men with erectile dysfunction (ED) associated with spinal cord injury (SCI), as well as its effects on the quality of life (QoL) of these patients.

NCT ID: NCT00547599 Completed - Impotence Clinical Trials

Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects

Start date: April 2003
Phase: Phase 4
Study type: Interventional

To determine if patients who are distressed over having problems getting or maintaining an erection react differently to the medication than those who are not stressed over the issue.

NCT ID: NCT00547573 Completed - Impotence Clinical Trials

Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection

Start date: April 2003
Phase: Phase 3
Study type: Interventional

Study to determine if tadalafil works better than placebo for Asian men having trouble getting or keeping an erection.

NCT ID: NCT00547508 Completed - Impotence Clinical Trials

To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking

Start date: October 2002
Phase: Phase 3
Study type: Interventional

Study to see how effective different doses of tadalafil are for getting and keeping an erection when sex is attempted after a certain number of hours.

NCT ID: NCT00547495 Completed - Impotence Clinical Trials

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

Start date: March 2004
Phase: Phase 3
Study type: Interventional

Study to determine how safe and effective tadalafil is for Japanese men taking it when they need to get and keep an erection.

NCT ID: NCT00547417 Completed - Impotence Clinical Trials

To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

Start date: July 2003
Phase: Phase 3
Study type: Interventional

To compare men of different races and those with diabetes or depression to white men that do not have diabetes or depression but also suffer from the inability to get or keep an erection.